Keywords: xoma, loss, falls, sales, soar, full-year, net
Xoma's 2007 loss falls 76% as sales soar 185%
Article | 24 March 2008
Full-year 2007 net loss at USA-based therapeutic antibodies developer Xoma was $12.3 million, or $0.10 per share, a reduction of 76.3% on the deficit ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
